RIPK3 and hepatocellular carcinoma: To investigate whether the undetectable RIPK3 in HCC may result in the deficiency in the necroptotic signaling in these cells, human HCC HepG2 cells were exposed to a combination treatment of TNF-α, birinapant and Z-VAD-FMK, a classic necroptosis-inducing condition.